Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results
Wednesday, December 11 2024 | 10 h 01 min | News
A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet...
Read MoreGene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this...
Read MoreGene Therapy for Vision Loss Approved by FDA
Thursday, January 25 2018 | 00 h 00 min | Vision Science
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in...
Read More